Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth
Authors
Keywords
-
Journal
CIRCULATION
Volume 145, Issue 15, Pages 1154-1168
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-03-23
DOI
10.1161/circulationaha.121.055920
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling After Myocardial Infarction
- (2021) Andrew J. Boyle et al. JAMA Cardiology
- To Be or Not to Be a CaMKII Inhibitor?
- (2021) Mark E. Anderson JAMA Cardiology
- MST4 Kinase Inhibitor Hesperadin Attenuates Autophagy and Behavioral Disorder via the MST4/AKT Pathway in Intracerebral Hemorrhage Mice
- (2020) Xiaodong Wu et al. BEHAVIOURAL NEUROLOGY
- The oral Ca/calmodulin‐dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure
- (2020) Julian Mustroph et al. ESC Heart Failure
- CaMKIIβ in Neuronal Development and Plasticity: An Emerging Candidate in Brain Diseases
- (2020) Olivier Nicole et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Christopher J L Murray et al. LANCET
- Glucose-sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis
- (2019) Hong-Kun Wu et al. CIRCULATION
- Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors
- (2019) Yongkun Sun et al. Journal of Hematology & Oncology
- The KN-93 Molecule Inhibits Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity by Binding to Ca2+/CaM
- (2019) Melanie H. Wong et al. JOURNAL OF MOLECULAR BIOLOGY
- High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma
- (2019) Sarah Wang et al. CLINICAL CANCER RESEARCH
- AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
- (2019) Jordi Bertran-Alamillo et al. Nature Communications
- CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repair
- (2019) Mao Zhang et al. NATURE CELL BIOLOGY
- Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
- (2019) Dominic P. Del Re et al. PHYSIOLOGICAL REVIEWS
- Regenerative Potential of Neonatal Porcine Hearts
- (2018) Wuqiang Zhu et al. CIRCULATION
- Fibronectin type III domain containing 5 attenuates NLRP3 inflammasome activation and phenotypic transformation of adventitial fibroblasts in spontaneously hypertensive rats
- (2018) Li Ling et al. JOURNAL OF HYPERTENSION
- The novel CaMKII inhibitor GS-680 reduces diastolic SR Ca leak and prevents CaMKII-dependent pro-arrhythmic activity
- (2018) S. Lebek et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Improvement of cardiomyocyte function by a novel pyrimidine-based CaMKII-inhibitor
- (2018) Stefan Neef et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
- (2018) Jeffrey C. Kwong et al. NEW ENGLAND JOURNAL OF MEDICINE
- CaMKII Isoforms in Learning and Memory: Localization and Function
- (2018) Gisela Zalcman et al. Frontiers in Molecular Neuroscience
- Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral
- (2017) Yanmei Hu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CaMKIIδ subtypes differentially regulate infarct formation following ex vivo myocardial ischemia/reperfusion through NF-κB and TNF-α
- (2017) Charles B.B. Gray et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- CaMKII is a nodal signal for multiple programmed cell death pathways in heart
- (2017) Ning Feng et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- CDYL Deficiency Disrupts Neuronal Migration and Increases Susceptibility to Epilepsy
- (2017) Rui Qin et al. Cell Reports
- Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal
- (2016) Olurotimi O. Mesubi et al. CARDIOVASCULAR RESEARCH
- The Biological Basis for Cardiac Repair After Myocardial Infarction
- (2016) Sumanth D. Prabhu et al. CIRCULATION RESEARCH
- CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosis
- (2016) Ting Zhang et al. NATURE MEDICINE
- KN-93 inhibits IKr in mammalian cardiomyocytes
- (2015) Bence Hegyi et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Human Ventricular Unloading Induces Cardiomyocyte Proliferation
- (2015) Diana C. Canseco et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors
- (2015) W. Xiong et al. MOLECULAR CANCER THERAPEUTICS
- Cardiotoxicity of anticancer treatments
- (2015) Michael S. Ewer et al. Nature Reviews Cardiology
- Chemically defined generation of human cardiomyocytes
- (2014) Paul W Burridge et al. NATURE METHODS
- Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos
- (2013) Nannan Chang et al. CELL RESEARCH
- Oxidized Ca 2+ /Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation
- (2013) Anil Purohit et al. CIRCULATION
- Myocardial ischemia-reperfusion injury: a neglected therapeutic target
- (2013) Derek J. Hausenloy et al. JOURNAL OF CLINICAL INVESTIGATION
- Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
- (2013) Linn Fagerberg et al. MOLECULAR & CELLULAR PROTEOMICS
- Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders
- (2013) Ruisheng Song et al. NATURE
- Ca2+/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity and Sinoatrial Nodal Pacemaker Cell Energetics
- (2013) Yael Yaniv et al. PLoS One
- Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling
- (2013) Adrian Britschgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Shortened Ca 2+ Signaling Refractoriness Underlies Cellular Arrhythmogenesis in a Postinfarction Model of Sudden Cardiac Death
- (2012) Andriy E. Belevych et al. CIRCULATION RESEARCH
- CaMKII determines mitochondrial stress responses in heart
- (2012) Mei-ling A. Joiner et al. NATURE
- A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies
- (2011) H.- T. Arkenau et al. ANNALS OF ONCOLOGY
- Oxidation of CaMKII determines the cardiotoxic effects of aldosterone
- (2011) B Julie He et al. NATURE MEDICINE
- CaMKII in the Cardiovascular System: Sensing Redox States
- (2011) Jeffrey R. Erickson et al. PHYSIOLOGICAL REVIEWS
- Improving a Natural CaMKII Inhibitor by Random and Rational Design
- (2011) Steven J. Coultrap et al. PLoS One
- Cell Death in the Pathogenesis of Heart Disease: Mechanisms and Significance
- (2010) Russell S. Whelan et al. Annual Review of Physiology
- MG53 Constitutes a Primary Determinant of Cardiac Ischemic Preconditioning
- (2010) Chun-Mei Cao et al. CIRCULATION
- Ryanodine Receptor Phosphorylation by Calcium/Calmodulin-Dependent Protein Kinase II Promotes Life-Threatening Ventricular Arrhythmias in Mice With Heart Failure
- (2010) Ralph J. van Oort et al. CIRCULATION
- Ca 2+ /Calmodulin-Dependent Kinase IIδ Causes Heart Failure by Accumulation of p53 in Dilated Cardiomyopathy
- (2010) Haruhiro Toko et al. CIRCULATION
- Inhibition of Elevated Ca 2+ /Calmodulin-Dependent Protein Kinase II Improves Contractility in Human Failing Myocardium
- (2010) Samuel Sossalla et al. CIRCULATION RESEARCH
- Ligand docking and binding site analysis with PyMOL and Autodock/Vina
- (2010) Daniel Seeliger et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Mitotic drivers—inhibitors of the Aurora B Kinase
- (2009) Nicholas Keen et al. CANCER AND METASTASIS REVIEWS
- Cardioprotection by CaMKII-δB Is Mediated by Phosphorylation of Heat Shock Factor 1 and Subsequent Expression of Inducible Heat Shock Protein 70
- (2009) Wei Peng et al. CIRCULATION RESEARCH
- Critical Role of Nuclear Calcium/Calmodulin-dependent Protein Kinase IIδB in Cardiomyocyte Survival in Cardiomyopathy
- (2009) Gillian H. Little et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Requirement for Ca2+/calmodulin–dependent kinase II in the transition from pressure overload–induced cardiac hypertrophy to heart failure in mice
- (2009) Haiyun Ling et al. JOURNAL OF CLINICAL INVESTIGATION
- GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models
- (2009) M. A. Hardwicke et al. MOLECULAR CANCER THERAPEUTICS
- Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs)
- (2008) Marija L. Mihajlovic et al. MOLECULAR SIMULATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started